🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Selected Advanced Solid Tumors

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites📍 Boston📍 St Louis📍 Hackensack BeOne Medicines · Tests: BG-C0979, Tislelizumab Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors NCT07387068Phase 112 sites📍 New Haven📍 Grand Rapids📍 Lake Success Genmab · Tests: GEN1079 Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors NCT05141474EARLY Phase 11 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD) Regimen, Interleukin-2 A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies NCT05473156Phase 1, Phase 21 site📍 Taipei AP Biosciences Inc. · Tests: AP203, AP203 Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors NCT07813000n/a1 site📍 Hangzhou Zhejiang University · Tests: Not applicable- observational study M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors NCT07166601Phase 15 sites📍 New Haven📍 New York📍 San Antonio EMD Serono Research & Development Institute, Inc. · Tests: M0324, M0324, Pembrolizumab, mFOLFIRINOX Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) NCT07044336Phase 3320 sites📍 Tucson📍 La Jolla📍 Los Angeles AstraZeneca · Tests: Puxitatug Samrotecan, Doxorubicin, Paclitaxel Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors NCT04643418Phase 1, Phase 21 site📍 Taipei MegaPro Biomedical Co. Ltd. · Tests: MPB-1734 Phase 1/2 Study of UI-102 in Selected Advanced Cancers NCT07605962Phase 1, Phase 23 sites📍 Dallas📍 Houston📍 San Antonio United Immunity, co., Ltd. · Tests: UI-102 A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3 NCT07807241Phase 17 sites📍 Sarasota📍 Atlanta📍 Baltimore Myricx Pharma Limited · Tests: MX006 A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors NCT06710379Phase 18 sites📍 Duarte📍 Santa Monica📍 Grand Rapids Adcentrx Therapeutics · Tests: ADRX-0405 Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors NCT07523529Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous dual-target CAR-T cells selected from the predefined target library., Fludarabine, Cyclophosphamide SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites📍 Glen Burnie📍 Pittsburgh📍 Seoul SK Life Science, Inc. · Tests: SKL35501, SKL35502 Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer NCT07589517Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DUO-CAR-NK-CEA/GCC, Lymphodepletion A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. NCT05867420Phase 1, Phase 24 sites📍 New York📍 Pittsburgh📍 Beijing AskGene Pharma, Inc. · Tests: ASKG915, Paclitaxel + Bevacizumab, Fruquintinib, Docetaxel ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours NCT06597721Phase 114 sites📍 Rogers📍 New Haven📍 Boston Adcendo ApS · Tests: ADCE-T02 A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors NCT07612189Phase 110 sites📍 Orlando📍 New York📍 Nashville NEOK Bio, Inc. · Tests: NEOK002, NEOK002 RDE Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations NCT06581432Phase 292 sites📍 Anchorage📍 Tucson📍 Beverly Hills Boehringer Ingelheim · Tests: Zongertinib Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial) NCT06311214Phase 229 sites📍 Duarte📍 Encinitas📍 Irvine National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Electronic Health Record Review A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours NCT06725758Phase 1, Phase 220 sites📍 Los Angeles📍 Orange📍 St Louis Orion Corporation, Orion Pharma · Tests: ODM-212 First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors NCT07438782Phase 120 sites📍 Philadelphia📍 San Antonio📍 Toronto GlaxoSmithKline · Tests: GSK5533524 TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma NCT04969315Phase 1, Phase 22 sites📍 Los Angeles📍 Houston Portage Biotech · Tests: TT-10, TT-4 A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors NCT07612176Phase 19 sites📍 New York📍 Nashville📍 Austin NEOK Bio, Inc. · Tests: NEOK001, NEOK001 RDE A Study of Sofe-M in Participants With Selected Advanced Solid Tumors NCT06400472Phase 125 sites📍 Scottsdale📍 La Jolla📍 Atlanta Eli Lilly and Company · Tests: Sofe-M, bevacizumab, carboplatin, Itraconazole, pembrolizumab A Study of LY4175408 in Participants With Advanced Cancer NCT07046923Phase 127 sites📍 Stanford📍 Orlando📍 Sarasota Eli Lilly and Company · Tests: LY4175408, Pembrolizumab, Carboplatin, Cisplatin First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors NCT06622486Phase 1, Phase 28 sites📍 Dijon📍 Montpellier📍 Paris Egle Therapeutics · Tests: EGL-001 A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites📍 Munich📍 Würzburg📍 Münster Kupando GmbH · Tests: KUP-101A A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites📍 Birmingham📍 Little Rock📍 Newport Beach Volastra Therapeutics, Inc. · Tests: Sovilnesib Clinical Trial of PM54 in Advanced Solid Tumors Patients. NCT05841563Phase 13 sites📍 San Antonio📍 Anderlecht📍 Madrid PharmaMar · Tests: PM54 AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors NCT07454642Phase 17 sites📍 Scottsdale📍 Sarasota📍 Chicago Avacta Life Sciences Ltd · Tests: AVA6103
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy